Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia

Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4552-7. doi: 10.1073/pnas.96.8.4552.

Abstract

Heterozygous mutations in the CD95 (APO-1/Fas) receptor occur in most individuals with autoimmune lymphoproliferative syndrome (ALPS) and dominantly interfere with apoptosis by an unknown mechanism. We show that local or global alterations in the structure of the cytoplasmic death domain from nine independent ALPS CD95 death-domain mutations result in a failure to bind the FADD/MORT1 signaling protein. Despite heterozygosity for the abnormal allele, lymphocytes from ALPS patients showed markedly decreased FADD association and a loss of caspase recruitment and activation after CD95 crosslinking. These data suggest that intracytoplasmic CD95 mutations in ALPS impair apoptosis chiefly by disrupting death-domain interactions with the signaling protein FADD/MORT1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adaptor Proteins, Signal Transducing*
  • Amino Acid Substitution
  • Apoptosis
  • Autoimmune Diseases / genetics*
  • Autoimmune Diseases / immunology*
  • Binding Sites
  • Carrier Proteins / metabolism
  • Codon, Terminator
  • Fas-Associated Death Domain Protein
  • Humans
  • Lymphoproliferative Disorders / genetics*
  • Lymphoproliferative Disorders / immunology*
  • Models, Molecular
  • Point Mutation
  • Protein Structure, Secondary
  • Sequence Deletion
  • Signal Transduction
  • Syndrome
  • fas Receptor / chemistry
  • fas Receptor / genetics*
  • fas Receptor / physiology

Substances

  • Adaptor Proteins, Signal Transducing
  • Carrier Proteins
  • Codon, Terminator
  • FADD protein, human
  • Fas-Associated Death Domain Protein
  • fas Receptor